A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

Clinical trial NCT07652047 · RECRUITING

Trial details

NCT number: NCT07652047
Sponsor: Corxel Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Obesity & Overweight

Start date: 2026-05-11
Primary completion: 2027-03-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.